insights_auto
Why is AQB down 5.75%?
Dive Deeperchevron_right
AQB:NASDAQ
Aquabounty Technologies Inc
US$0.87
arrow_downward
-5.75%(-0.053) 1D
ኖቬም 12, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AQB...
Open
US$0.93
High
US$0.93
Low
US$0.83
Mkt. cap
11.61 ሚ
Avg. vol.
69.93 ሺ
Volume
68.15 ሺ
52-wk high
US$1.64
52-wk low
US$0.77
EPS
-US$4.58
Beta
1.45
Shares outstanding
13.29 ሚ
No. of employees
3
Open
US$0.93
High
US$0.93
Low
US$0.83
Mkt. cap
11.61 ሚ
Avg. vol.
69.93 ሺ
Volume
68.15 ሺ
52-wk high
US$1.64
52-wk low
US$0.77
EPS
-US$4.58
Beta
1.45
Shares outstanding
13.29 ሚ
No. of employees
3
News stories
From web sources and news partners
TradingView
·
ከ1 ሰዓት በፊት
Oragenics gets until February 2028 to regain NYSE listing compliance
Investing.com
·
ከ9 ደቂቃዎች በፊት
FreeCast notifies Nasdaq of audit committee noncompliance after director resignation
TV News Check
·
ከ16 ደቂቃዎች በፊት
Dow Dips 189, Nasdaq Sinks 100, S&P 500 Falls 27
Yahoo Finance
·
ከ1 ሰዓት በፊት
S&P 500 Recovered $1 Trillion in 90 Minutes Despite Wider Market Crash
Profile
AquaBounty Technologies is a biotechnology and aquaculture company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of the company's AquAdvantage salmon has been approved in Canada and the United States. The company sold all of its operating farms and ceased fish production in 2024. Wikipedia
About Aquabounty Technologies Inc
CEO-
Employees3
Founded1991
HeadquartersHarvard, ማሣቹሰትስ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websiteaquabounty.com